Home
Know AML
Know AML
Agenda
17:30 (BST)
Charles Craddock

Welcome and introductions

  • Meeting objectives
  • Introduction to the speakers
17:35 (BST)
Charles Craddock

What are mutations, and why do they matter in AML?

  • Introduction to mutations and mutation testing
  • The importance of mutations in AML: Diagnosis and personalized treatment decisions
17:45 (BST)
Gail J. RobozRalph Hills

Empowering patients to ask their physician the right questions during their AML journey

  • Patients’ experiences with mutation testing during AML diagnosis and treatment
  • Mutation testing methods: How far have we come?
  • How patients can access testing
  • Making decisions together
18:15 (BST)
Gail J. RobozRalph Hills

Takeaway action points: How can physicians and patients communicate more clearly about mutation testing in AML going forward?

  • The role of the physician
  • The role of the patient
18:25 (BST)
Charles Craddock

Closing remarks

  • Links to credible resources
  • Post-webinar evaluation

Learning objectives

The webinar will focus on achieving the following learning objectives:

  • Increase attendees’ knowledge of the biology of AML and mutations
  • Share knowledge of the diagnostic process and the role of genetics in diagnosis and treatment
  • Identify relevant disease-specific questions for patient–HCP discussions
  • Increase effective patient–HCP communication and shared decision-making

Registration form

Registration is free. Please complete the form and submit to register.


Know AML uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy